Company Overview of Cellicon Biotechnologies, Inc.
Cellicon Biotechnologies, Inc, develops technologies for decoding the protein pathway for the cure of human diseases such as diabetes, arthritis, and cancer. The company was founded in 2002 and is based Boston, Massachusetts.
650 Beacon Street
Boston, MA 02215-2015
Founded in 2002
Key Executives for Cellicon Biotechnologies, Inc.
Similar Private Companies By Industry
|20n Labs, Inc.||United States|
|23andMe, Inc.||United States|
|2C Tech Corporation, Inc.||United States|
|3-V Biosciences, Inc.||United States|
|3Bar Biologics Inc.||United States|
Recent Private Companies Transactions
|No transactions available in the past 12 months.|
The information and data displayed in this profile are created and managed by S&P Global Market Intelligence, a division of S&P Global. Bloomberg.com does not create or control the content. For inquiries, please contact S&P Global Market Intelligence directly by clicking here.
Most Searched Private Companies
|Company Name||Geographic Region|
|Lawyers Committee for Civil Rights Under Law||United States|
|Bloomberg L.P.||United States|
|The Advertising Council, Inc.||United States|
|Rush University||United States|
Sponsored Financial Commentaries
Only a company representative may request an update for the company profile. Documentation will be required.
To contact Cellicon Biotechnologies, Inc., please visit www.cellicon.com. Company data is provided by S&P Global Market Intelligence. Please use this form to report any data issues.